Corteva, Inc. (CTVA) Stock Forecast
Data as of Aug 1, 2026Basic Materials · Current price $79.55 (-11.28%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 9, 2026 | Joshua Spector | UBS | $80.00 | +0.6% |
| Jan 16, 2026 | Edlain Rodriguez | Mizuho Securities | $80.00 | +0.6% |
| Jul 15, 2025 | Kristen Owen | Oppenheimer | $87.00 | +9.4% |
| Apr 14, 2025 | Aleksey Yefremov | KeyBanc | $71.00 | -10.7% |
| Nov 21, 2024 | Aleksey Yefremov | KeyBanc | $69.00 | -13.3% |
| Oct 23, 2024 | Patrick Cunningham | Citigroup | $68.00 | -14.5% |
| Oct 16, 2024 | Steve Byrne | Bank of America Securities | $67.00 | -15.8% |
| Sep 25, 2024 | John Roberts | Mizuho Securities | $61.00 | -23.3% |
| Sep 17, 2024 | Kriten Owen | Oppenheimer | $69.00 | -13.3% |
| Aug 2, 2024 | Aleksey Yefremov | KeyBanc | $62.00 | -22.1% |
| Jun 18, 2024 | John Roberts | Mizuho Securities | $60.00 | -24.6% |
| Jun 11, 2024 | Chris Parkinson | Wolfe Research | $68.00 | -14.5% |
| May 6, 2024 | David Begleiter | Deutsche Bank | $65.00 | -18.3% |
| May 6, 2024 | Arun Viswanathan | RBC Capital | $64.00 | -19.5% |
| May 3, 2024 | Bobby Burleson | Canaccord Genuity | $65.00 | -18.3% |
| May 3, 2024 | Joel Jackson | BMO Capital | $67.00 | -15.8% |
| Mar 28, 2024 | Laurence Alexander | Jefferies | $67.00 | -15.8% |
| Feb 12, 2024 | Christopher Kapsch | Loop Capital Markets | $65.00 | -18.3% |
| Feb 2, 2024 | Laurent Favre | BNP Paribas | $53.00 | -33.4% |
| Jul 14, 2022 | John Roberts | Credit Suisse | $68.00 | -14.5% |
Top Analysts Covering CTVA
CTVA vs Sector & Market
| Metric | CTVA | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.30 | 2.36 | 2.42 |
| Analyst Count | 20 | 7 | 19 |
| Target Upside | +15.7% | +120.2% | +17.1% |
| P/E Ratio | 46.79 | -10.82 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $17.76B | $18.10B | $18.31B | 15 |
| 2027-03-31 | $4.71B | $4.81B | $4.90B | 4 |
| 2027-06-30 | $6.75B | $6.89B | $7.02B | 4 |
| 2027-09-30 | $2.69B | $2.75B | $2.80B | 5 |
| 2027-12-31 | $4.23B | $4.32B | $4.40B | 4 |
| 2028-03-31 | $4.93B | $5.03B | $5.13B | 3 |
| 2028-06-30 | $7.06B | $7.21B | $7.34B | 3 |
| 2028-09-30 | $2.80B | $2.86B | $2.91B | 5 |
| 2028-12-31 | $4.57B | $4.67B | $4.76B | 3 |
| 2029-12-31 | $18.93B | $19.29B | $19.70B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.56 | $3.67 | $3.87 | 11 |
| 2027-03-31 | $1.22 | $1.26 | $1.29 | 4 |
| 2027-06-30 | $2.43 | $2.50 | $2.56 | 4 |
| 2027-09-30 | $-0.29 | $-0.28 | $-0.27 | 4 |
| 2027-12-31 | $0.47 | $0.48 | $0.50 | 4 |
| 2028-03-31 | $1.35 | $1.39 | $1.42 | 5 |
| 2028-06-30 | $2.66 | $2.74 | $2.80 | 5 |
| 2028-09-30 | $-0.34 | $-0.33 | $-0.32 | 5 |
| 2028-12-31 | $0.56 | $0.58 | $0.59 | 5 |
| 2029-12-31 | $4.98 | $5.10 | $5.24 | 1 |
Frequently Asked Questions
What is the analyst consensus for CTVA?
The consensus among 20 analysts covering Corteva, Inc. (CTVA) is Buy with an average price target of $89.13.
What is the highest price target for CTVA?
The highest price target for CTVA is $87.00, set by Kristen Owen at Oppenheimer on 2025-07-15.
What is the lowest price target for CTVA?
The lowest price target for CTVA is $42.00, set by Steve Byrne at Bank of America Securities on 2021-05-10.
How many analysts cover CTVA?
20 analysts have issued ratings for Corteva, Inc. in the past 12 months.
Is CTVA a buy or sell right now?
Based on 20 analyst ratings, CTVA has a consensus rating of Buy (2.30/5) with a +15.7% upside to the consensus target of $89.13.
What are the earnings estimates for CTVA?
Analysts estimate CTVA will report EPS of $3.67 for the period ending 2026-12-31, with revenue estimated at $18.10B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.